Parkman Healthcare Partners
Latest statistics and disclosures from Parkman Healthcare Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BSX, UTHR, BDX, DXCM, COO, and represent 24.49% of Parkman Healthcare Partners's stock portfolio.
- Added to shares of these 10 stocks: DXCM (+$17M), HCA (+$14M), CRL (+$8.7M), COO (+$8.0M), ZBH (+$8.0M), TMO (+$7.8M), BSX (+$6.6M), AMGN (+$5.4M), HUM, APLT.
- Started 22 new stock positions in CUTR, ZBH, CRL, URGN, AMGN, CRNX, TMO, EW, ABOS, TNGX. INSM, Ambrx Biopharma, GPCR, LAB, MORF, HCA, BBIO, AUGX, ETON, SLNO, APLT, IRWD.
- Reduced shares in these 10 stocks: DHR (-$15M), LNTH (-$14M), WAT (-$11M), NBIX (-$6.3M), Seagen, MMS, IMVT, ANIP, SAGE, RXST.
- Sold out of its positions in AXGN, CDTX, DHR, GRTX, IMVT, MRNS, MMS, MLYS, NSTG, KRMD. SAGE, SVRA, Seagen, SWAV, WAT.
- Parkman Healthcare Partners was a net buyer of stock by $43M.
- Parkman Healthcare Partners has $546M in assets under management (AUM), dropping by -5.39%.
- Central Index Key (CIK): 0001777015
Tip: Access up to 7 years of quarterly data
Positions held by Parkman Healthcare Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 102 positions in its portfolio as reported in the September 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Boston Scientific Corporation (BSX) | 5.8 | $32M | +26% | 597k | 52.80 |
|
United Therapeutics Corporation (UTHR) | 5.7 | $31M | +12% | 138k | 225.87 |
|
Becton, Dickinson and (BDX) | 4.6 | $25M | +17% | 98k | 258.53 |
|
Dex (DXCM) | 4.5 | $25M | +211% | 266k | 93.30 |
|
Cooper Cos Com New (COO) | 3.8 | $21M | +62% | 65k | 318.01 |
|
AmerisourceBergen (COR) | 3.2 | $17M | +12% | 97k | 179.97 |
|
Tenet Healthcare Corp Com New (THC) | 2.7 | $15M | -10% | 226k | 65.89 |
|
Hca Holdings (HCA) | 2.5 | $14M | NEW | 56k | 245.98 |
|
Vaxcyte (PCVX) | 2.2 | $12M | +4% | 238k | 50.98 |
|
ImmunoGen (IMGN) | 2.1 | $11M | -14% | 718k | 15.87 |
|
Rxsight (RXST) | 1.9 | $11M | -23% | 381k | 27.89 |
|
Schrodinger (SDGR) | 1.9 | $10M | -23% | 369k | 28.27 |
|
Humana (HUM) | 1.9 | $10M | +90% | 21k | 486.52 |
|
Keros Therapeutics (KROS) | 1.7 | $9.5M | +7% | 299k | 31.88 |
|
Neurocrine Biosciences (NBIX) | 1.7 | $9.4M | -39% | 84k | 112.50 |
|
Kiniksa Pharmaceuticals Com Cl A (KNSA) | 1.6 | $8.9M | +74% | 510k | 17.37 |
|
Karuna Therapeutics Ord (KRTX) | 1.6 | $8.7M | +4% | 51k | 169.09 |
|
Charles River Laboratories (CRL) | 1.6 | $8.7M | NEW | 44k | 195.98 |
|
Mannkind Corp Com New (MNKD) | 1.6 | $8.5M | +13% | 2.1M | 4.13 |
|
Haemonetics Corporation (HAE) | 1.5 | $8.0M | -22% | 89k | 89.58 |
|
Zimmer Holdings (ZBH) | 1.5 | $8.0M | NEW | 71k | 112.22 |
|
Thermo Fisher Scientific (TMO) | 1.4 | $7.8M | NEW | 15k | 506.17 |
|
Deciphera Pharmaceuticals (DCPH) | 1.4 | $7.6M | +4% | 597k | 12.72 |
|
Xenon Pharmaceuticals (XENE) | 1.4 | $7.4M | 217k | 34.16 |
|
|
Arcellx Common Stock (ACLX) | 1.3 | $7.3M | +4% | 204k | 35.88 |
|
Ionis Pharmaceuticals (IONS) | 1.3 | $7.2M | +4% | 160k | 45.36 |
|
Verona Pharma Sponsored Ads (VRNA) | 1.2 | $6.8M | +4% | 418k | 16.30 |
|
Insulet Corporation (PODD) | 1.2 | $6.7M | -27% | 42k | 159.49 |
|
Biosante Pharmaceuticals (ANIP) | 1.2 | $6.5M | -35% | 112k | 58.06 |
|
Akero Therapeutics (AKRO) | 1.1 | $5.9M | +231% | 116k | 50.58 |
|
Day One Biopharmaceuticals I (DAWN) | 1.0 | $5.7M | +8% | 466k | 12.27 |
|
89bio (ETNB) | 1.0 | $5.6M | +4% | 364k | 15.44 |
|
Amgen (AMGN) | 1.0 | $5.4M | NEW | 20k | 268.76 |
|
Inspire Med Sys (INSP) | 1.0 | $5.3M | +86% | 27k | 198.44 |
|
Travere Therapeutics (TVTX) | 0.9 | $5.2M | +294% | 578k | 8.94 |
|
Veracyte (VCYT) | 0.9 | $5.0M | +6% | 226k | 22.33 |
|
Applied Therapeutics (APLT) | 0.8 | $4.4M | NEW | 1.8M | 2.49 |
|
Sutro Biopharma (STRO) | 0.8 | $4.1M | +3% | 1.2M | 3.47 |
|
Cullinan Oncology (CGEM) | 0.7 | $4.0M | +26% | 439k | 9.05 |
|
Supernus Pharmaceuticals (SUPN) | 0.7 | $3.8M | -27% | 138k | 27.57 |
|
Castle Biosciences (CSTL) | 0.7 | $3.8M | +51% | 225k | 16.89 |
|
Silk Road Medical Inc Common (SILK) | 0.7 | $3.7M | -18% | 249k | 14.99 |
|
Arcus Biosciences Incorporated (RCUS) | 0.7 | $3.7M | +70% | 205k | 17.95 |
|
Catalent (CTLT) | 0.7 | $3.7M | -42% | 81k | 45.53 |
|
Ideaya Biosciences (IDYA) | 0.7 | $3.6M | +4% | 133k | 26.98 |
|
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.6 | $3.5M | -79% | 50k | 69.48 |
|
CVRX (CVRX) | 0.6 | $3.4M | +57% | 222k | 15.17 |
|
Si-bone (SIBN) | 0.6 | $3.3M | +11% | 155k | 21.24 |
|
Insmed Com Par $.01 (INSM) | 0.6 | $3.2M | NEW | 125k | 25.25 |
|
Syndax Pharmaceuticals (SNDX) | 0.6 | $3.1M | +2% | 212k | 14.52 |
|
Merus N V (MRUS) | 0.6 | $3.1M | +92% | 131k | 23.58 |
|
Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.6 | $3.0M | -33% | 53k | 57.00 |
|
Neogenomics Com New (NEO) | 0.6 | $3.0M | +4% | 246k | 12.30 |
|
Crinetics Pharmaceuticals In (CRNX) | 0.5 | $3.0M | NEW | 100k | 29.74 |
|
Establishment Labs Holdings Ord (ESTA) | 0.5 | $3.0M | +4% | 61k | 49.07 |
|
Soleno Therapeutics (SLNO) | 0.5 | $3.0M | NEW | 100k | 29.51 |
|
Performant Finl (PFMT) | 0.5 | $2.9M | -10% | 1.3M | 2.26 |
|
Evolent Health Cl A (EVH) | 0.5 | $2.8M | -13% | 103k | 27.23 |
|
Edwards Lifesciences (EW) | 0.5 | $2.8M | NEW | 40k | 69.28 |
|
Edgewise Therapeutics (EWTX) | 0.5 | $2.7M | +4% | 473k | 5.73 |
|
Bridgebio Pharma (BBIO) | 0.5 | $2.6M | NEW | 100k | 26.37 |
|
Bicycle Therapeutics Sponsored Ads (BCYC) | 0.5 | $2.5M | -28% | 123k | 20.09 |
|
Disc Medicine (IRON) | 0.4 | $2.4M | +4% | 52k | 46.98 |
|
Akoya Biosciences (AKYA) | 0.4 | $2.4M | +11% | 526k | 4.65 |
|
Lyra Therapeutics (LYRA) | 0.4 | $2.4M | +4% | 625k | 3.91 |
|
ACADIA Pharmaceuticals (ACAD) | 0.4 | $2.4M | +15% | 116k | 20.84 |
|
Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.4 | $2.3M | +4% | 249k | 9.25 |
|
Natera (NTRA) | 0.4 | $2.2M | -32% | 51k | 44.25 |
|
Quanterix Ord (QTRX) | 0.4 | $2.1M | +53% | 77k | 27.14 |
|
Acumen Pharmaceuticals (ABOS) | 0.4 | $2.1M | NEW | 500k | 4.15 |
|
Mirum Pharmaceuticals (MIRM) | 0.4 | $2.1M | +4% | 65k | 31.60 |
|
Arvinas Ord (ARVN) | 0.4 | $2.0M | +4% | 104k | 19.64 |
|
Urogen Pharma (URGN) | 0.4 | $2.0M | NEW | 145k | 14.01 |
|
Longboard Pharmaceuticals In (LBPH) | 0.4 | $2.0M | +4% | 356k | 5.56 |
|
Esperion Therapeutics (ESPR) | 0.4 | $2.0M | -6% | 2.0M | 0.98 |
|
Augmedix (AUGX) | 0.4 | $1.9M | NEW | 376k | 5.15 |
|
Silence Therapeutics Ads (SLN) | 0.3 | $1.9M | +4% | 193k | 9.82 |
|
Cogent Biosciences (COGT) | 0.3 | $1.9M | +4% | 194k | 9.75 |
|
Pacific Biosciences of California (PACB) | 0.3 | $1.8M | -35% | 211k | 8.35 |
|
Peregrine Pharmaceuticals (CDMO) | 0.3 | $1.8M | +4% | 186k | 9.44 |
|
Tg Therapeutics (TGTX) | 0.3 | $1.7M | -5% | 209k | 8.36 |
|
Ambrx Biopharma Sponsored Ads | 0.3 | $1.7M | NEW | 150k | 11.50 |
|
Morphic Hldg (MORF) | 0.3 | $1.7M | NEW | 75k | 22.91 |
|
Tango Therapeutics (TNGX) | 0.3 | $1.5M | NEW | 136k | 11.26 |
|
Structure Therapeutics Sponsored Ads (GPCR) | 0.3 | $1.5M | NEW | 30k | 50.42 |
|
Black Diamond Therapeutics (BDTX) | 0.3 | $1.5M | +4% | 521k | 2.87 |
|
D Fluidigm Corp Del (LAB) | 0.3 | $1.5M | NEW | 500k | 2.90 |
|
Tela Bio (TELA) | 0.2 | $1.3M | +4% | 167k | 8.00 |
|
Lexicon Pharmaceuticals Com New (LXRX) | 0.2 | $1.2M | -14% | 1.1M | 1.09 |
|
Aclaris Therapeutics (ACRS) | 0.2 | $971k | -26% | 142k | 6.85 |
|
Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.2 | $963k | NEW | 100k | 9.63 |
|
X4 Pharmaceuticals (XFOR) | 0.2 | $872k | -78% | 800k | 1.09 |
|
Immunic (IMUX) | 0.2 | $827k | +4% | 563k | 1.47 |
|
Liquidia Corporation Com New (LQDA) | 0.1 | $743k | -58% | 117k | 6.34 |
|
Inozyme Pharma (INZY) | 0.1 | $739k | +4% | 176k | 4.20 |
|
Aslan Pharmaceuticals Spon Ads New (ASLN) | 0.1 | $701k | -26% | 373k | 1.88 |
|
Eton Pharmaceuticals (ETON) | 0.1 | $688k | NEW | 165k | 4.17 |
|
Alpha Teknova (TKNO) | 0.1 | $652k | +32% | 234k | 2.79 |
|
Cutera (CUTR) | 0.1 | $602k | NEW | 100k | 6.02 |
|
Acutus Medical (AFIB) | 0.1 | $553k | +4% | 794k | 0.70 |
|
Voyager Therapeutics (VYGR) | 0.1 | $468k | +4% | 60k | 7.75 |
|
Terns Pharmaceuticals (TERN) | 0.0 | $210k | -59% | 42k | 5.03 |
|
Past Filings by Parkman Healthcare Partners
SEC 13F filings are viewable for Parkman Healthcare Partners going back to 2019
- Parkman Healthcare Partners 2023 Q3 filed Nov. 14, 2023
- Parkman Healthcare Partners 2023 Q2 filed Aug. 11, 2023
- Parkman Healthcare Partners 2023 Q1 filed May 12, 2023
- Parkman Healthcare Partners 2022 Q4 filed Feb. 13, 2023
- Parkman Healthcare Partners 2022 Q3 filed Nov. 14, 2022
- Parkman Healthcare Partners 2022 Q2 filed Aug. 12, 2022
- Parkman Healthcare Partners 2022 Q1 filed May 13, 2022
- Parkman Healthcare Partners 2021 Q4 filed Feb. 11, 2022
- Parkman Healthcare Partners 2021 Q3 filed Nov. 12, 2021
- Parkman Healthcare Partners 2021 Q2 filed Aug. 13, 2021
- Parkman Healthcare Partners 2021 Q1 filed May 14, 2021
- Parkman Healthcare Partners 2020 Q4 filed Feb. 12, 2021
- Parkman Healthcare Partners 2020 Q3 filed Nov. 13, 2020
- Parkman Healthcare Partners 2020 Q2 filed Aug. 13, 2020
- Parkman Healthcare Partners 2020 Q1 filed May 15, 2020
- Parkman Healthcare Partners 2019 Q4 filed Feb. 13, 2020